Paper12547827
Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor.
Sun JP and 7 others. J Biol Chem, 2003. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. Papers, record 12547827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12547827
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phenylalanine | Major topic |
| Protein Tyrosine Phosphatases | Major topic |
| Alkanesulfonic Acids | |
| Binding Sites | |
| Crystallography | |
| Humans | |
| Kinetics | |
| Morpholines | |
| Mutagenesis, Site-Directed | |
| Protein Structure, Secondary | |
| Protein Structure, Tertiary | |
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | |
| Vanadates |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM55242 | NIGMS NIH HHS | United States | R01GM055242 | PubMed and NIH |
Source NIH RePORTER
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42714812 | Recent advances of dual PROTACs for potential therapeutic applications. | Mol Divers | 2026 | https://conductscience.org/library/papers/42714812 | PubMed |
| 39458839 | Exploring the Antidiabetic Potential of Salvia officinalis Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions. | Plants (Basel) | 2024 | https://conductscience.org/library/papers/39458839 | PubMed |
| 38768084 | Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases. | J Med Chem | 2024 | https://conductscience.org/library/papers/38768084 | PubMed |
| 37711015 | Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview. | Curr Med Chem | 2024 | https://conductscience.org/library/papers/37711015 | PubMed |
| 36973833 | Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy. | Angew Chem Int Ed Engl | 2023 | https://conductscience.org/library/papers/36973833 | PubMed |
| 36837781 | Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach. | Metabolites | 2023 | https://conductscience.org/library/papers/36837781 | PubMed |
| 35303375 | Pentafluorophosphato-Phenylalanines: Amphiphilic Phosphotyrosine Mimetics Displaying Fluorine-Specific Protein Interactions. | Angew Chem Int Ed Engl | 2022 | https://conductscience.org/library/papers/35303375 | PubMed |
| 34677434 | Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes. | Mar Drugs | 2021 | https://conductscience.org/library/papers/34677434 | PubMed |
| 34655403 | Discovery of inhibitors targeting protein tyrosine phosphatase 1B using a combined virtual screening approach. | Mol Divers | 2022 | https://conductscience.org/library/papers/34655403 | PubMed |
| 33571432 | Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes. | Cell | 2021 | https://conductscience.org/library/papers/33571432 | PubMed |
| 33003469 | Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33003469 | PubMed |
| 31298844 | An Isoform-Selective PTP1B Inhibitor Derived from Nitrogen-Atom Augmentation of Radicicol. | Biochemistry | 2019 | https://conductscience.org/library/papers/31298844 | PubMed |
| 30979725 | Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30979725 | PubMed |
| 30299094 | Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors. | J Chem Inf Model | 2018 | https://conductscience.org/library/papers/30299094 | PubMed |
| 29414924 | VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition. | Molecules | 2018 | https://conductscience.org/library/papers/29414924 | PubMed |
| 28451373 | Enzyme-triggered compound release using functionalized antimicrobial peptide derivatives. | Chem Sci | 2017 | https://conductscience.org/library/papers/28451373 | PubMed |
| 27095436 | A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation. | J Neuroinflammation | 2016 | https://conductscience.org/library/papers/27095436 | PubMed |
| 26435211 | Protein Tyrosine Phosphatases in Hypothalamic Insulin and Leptin Signaling. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/26435211 | PubMed |
| 26057789 | Structure of human dual-specificity phosphatase 7, a potential cancer drug target. | Acta Crystallogr F Struct Biol Commun | 2015 | https://conductscience.org/library/papers/26057789 | PubMed |
| 25081058 | The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes. | Cell Res | 2014 | https://conductscience.org/library/papers/25081058 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| LEP | 3952 | PubTator's text mining | https://conductscience.org/library/genes/3952 | NCBI Gene |
| PTPN1 | 5770 | PubTator's text mining | https://conductscience.org/library/genes/5770 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| PDB | 1N6W |
Source PDB
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12547827
GET https://conductscience.org/api/papers/v1/12547827/cited_by?page=2